<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>San Diego Biotechnology Network: Life Science Events, Jobs, News, Companies, Directory, Blog, &#38; Calendar &#187; Xconomy</title>
	<atom:link href="http://sdbn.org/category/sdbiotechnews/xconomy/feed/" rel="self" type="application/rss+xml" />
	<link>http://sdbn.org</link>
	<description>sdbn.org</description>
	<lastBuildDate>Tue, 07 Feb 2012 08:00:19 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
		<item>
		<title>Applied Proteomics, Co-Founded by Danny Hillis, Gets New CEO, $22.5M</title>
		<link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/Ymdfl_oQ3o8/</link>
		<comments>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/Ymdfl_oQ3o8/#comments</comments>
		<pubDate>Tue, 07 Feb 2012 08:00:19 +0000</pubDate>
		<dc:creator>sandiegobiotech</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Syndication]]></category>
		<category><![CDATA[Xconomy]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[san diego]]></category>
		<category><![CDATA[vc]]></category>
		<category><![CDATA[venture capital]]></category>

		<guid isPermaLink="false">http://www.xconomy.com/?p=178032</guid>
		<description><![CDATA[Applied Proteomics hasn’t exactly been operating in stealth mode since it was founded five years ago. Co-founders David Agus, a cancer specialist at USC, and Danny Hillis, the MIT-trained computer...

[[Click headline to continue reading.]]]]></description>
			<content:encoded><![CDATA[Applied Proteomics hasn’t exactly been operating in stealth mode since it was founded five years ago. Co-founders David Agus, a cancer specialist at USC, and Danny Hillis, the MIT-trained computer...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/Ymdfl_oQ3o8" height="1" width="1"/>]]></content:encoded>
			<wfw:commentRss>http://www.xconomy.com/san-diego/2012/02/07/applied-proteomics-co-founded-by-danny-hillis-gets-new-ceo-22-5m/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA vs. Drug Ads: Cut the Kids and Dogs, Spell Out Side Effects</title>
		<link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/P_0TfV6yg-s/</link>
		<comments>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/P_0TfV6yg-s/#comments</comments>
		<pubDate>Mon, 06 Feb 2012 12:00:02 +0000</pubDate>
		<dc:creator>sandiegobiotech</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Syndication]]></category>
		<category><![CDATA[Xconomy]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[Pfizer]]></category>

		<guid isPermaLink="false">http://www.xconomy.com/?p=177676</guid>
		<description><![CDATA[If you’ve turned on your TV anytime in the last, oh, decade or so, you’ve no doubt been bombarded by ads imploring you to “ask your doctor” about Drug X. And you’re well familiar with the routine:...

[[Click headline to continue reading.]]]]></description>
			<content:encoded><![CDATA[If you’ve turned on your TV anytime in the last, oh, decade or so, you’ve no doubt been bombarded by ads imploring you to “ask your doctor” about Drug X. And you’re well familiar with the routine:...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/P_0TfV6yg-s" height="1" width="1"/>]]></content:encoded>
			<wfw:commentRss>http://www.xconomy.com/national/2012/02/06/fda-vs-drug-ads-cut-the-kids-and-dogs-spell-out-side-effects/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>San Diego Life Sciences Roundup: Amylin, Optimer, and the Economy</title>
		<link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/0tvsbgzByh0/</link>
		<comments>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/0tvsbgzByh0/#comments</comments>
		<pubDate>Fri, 03 Feb 2012 15:48:41 +0000</pubDate>
		<dc:creator>sandiegobiotech</dc:creator>
				<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Syndication]]></category>
		<category><![CDATA[Xconomy]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[pharma]]></category>
		<category><![CDATA[san diego]]></category>

		<guid isPermaLink="false">http://www.xconomy.com/?p=177539</guid>
		<description><![CDATA[—San Diego’s Amylin Pharmaceuticals says Bydureon, its new once-a-week drug for treating Type 2 diabetes can hit the market as early as next month, after the FDA cleared Bydureon. The FDA rejected...

[[Click headline to continue reading.]]]]></description>
			<content:encoded><![CDATA[—San Diego’s Amylin Pharmaceuticals says Bydureon, its new once-a-week drug for treating Type 2 diabetes can hit the market as early as next month, after the FDA cleared Bydureon. The FDA rejected...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/0tvsbgzByh0" height="1" width="1"/>]]></content:encoded>
			<wfw:commentRss>http://www.xconomy.com/san-diego/2012/02/03/san-diego-life-sciences-roundup-amylin-optimer-and-the-economy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>San Diego Life Sciences Strengthened in Recession, Outpacing Nation</title>
		<link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/CiUVPWL9QqU/</link>
		<comments>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/CiUVPWL9QqU/#comments</comments>
		<pubDate>Wed, 01 Feb 2012 19:16:56 +0000</pubDate>
		<dc:creator>sandiegobiotech</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Syndication]]></category>
		<category><![CDATA[Xconomy]]></category>
		<category><![CDATA[biofuels]]></category>
		<category><![CDATA[economy]]></category>
		<category><![CDATA[Funding/Resources]]></category>
		<category><![CDATA[pharma]]></category>
		<category><![CDATA[san diego]]></category>

		<guid isPermaLink="false">http://www.xconomy.com/?p=177235</guid>
		<description><![CDATA[Employment in San Diego’s life sciences sector grew by 15 percent over the past two years, as biopharmas, medical device companies, and other employers added roughly 5,550 jobs here—raising...

[[Click headline to continue reading.]]]]></description>
			<content:encoded><![CDATA[Employment in San Diego’s life sciences sector grew by 15 percent over the past two years, as biopharmas, medical device companies, and other employers added roughly 5,550 jobs here—raising...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/CiUVPWL9QqU" height="1" width="1"/>]]></content:encoded>
			<wfw:commentRss>http://www.xconomy.com/san-diego/2012/02/01/san-diego-life-sciences-strengthened-in-recession-outpacing-nation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vertex’s Big Day Felt Like Moon Landing, Seattle Researcher Says</title>
		<link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/SiqsVxse0FU/</link>
		<comments>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/SiqsVxse0FU/#comments</comments>
		<pubDate>Wed, 01 Feb 2012 09:05:33 +0000</pubDate>
		<dc:creator>sandiegobiotech</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Syndication]]></category>
		<category><![CDATA[Xconomy]]></category>
		<category><![CDATA[biotech]]></category>

		<guid isPermaLink="false">http://www.xconomy.com/?p=177125</guid>
		<description><![CDATA[Bonnie Ramsey said three years ago that a cystic fibrosis drug from Vertex Pharmaceuticals was a huge medical advance in the making, and would end up being an achievement on par with putting a man on...

[[Click headline to continue reading.]]]]></description>
			<content:encoded><![CDATA[Bonnie Ramsey said three years ago that a cystic fibrosis drug from Vertex Pharmaceuticals was a huge medical advance in the making, and would end up being an achievement on par with putting a man on...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/SiqsVxse0FU" height="1" width="1"/>]]></content:encoded>
			<wfw:commentRss>http://www.xconomy.com/boston/2012/02/01/vertexs-big-day-felt-like-moon-landing-seattle-researcher-says/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vertex Gets FDA Go-Ahead To Sell New Cystic Fibrosis Drug</title>
		<link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/oW4Zts_jZas/</link>
		<comments>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/oW4Zts_jZas/#comments</comments>
		<pubDate>Tue, 31 Jan 2012 16:47:49 +0000</pubDate>
		<dc:creator>sandiegobiotech</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Syndication]]></category>
		<category><![CDATA[Xconomy]]></category>
		<category><![CDATA[biotech]]></category>

		<guid isPermaLink="false">http://www.xconomy.com/?p=177043</guid>
		<description><![CDATA[[Updated: 1:25 pm] Vertex Pharmaceuticals is now officially more than just a one-hit wonder. The Cambridge, MA-based biotech company (NASDAQ: VRTX), best known for its hepatitis C drug, has won...

[[Click headline to continue reading.]]]]></description>
			<content:encoded><![CDATA[[Updated: 1:25 pm] Vertex Pharmaceuticals is now officially more than just a one-hit wonder. The Cambridge, MA-based biotech company (NASDAQ: VRTX), best known for its hepatitis C drug, has won...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/oW4Zts_jZas" height="1" width="1"/>]]></content:encoded>
			<wfw:commentRss>http://www.xconomy.com/boston/2012/01/31/vertex-gets-fda-go-ahead-to-sell-new-cystic-fibrosis-drug/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Optimer, Following Pfizer’s Playbook, Has Big Plans for Antibiotic</title>
		<link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/dT5LxH1sWEE/</link>
		<comments>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/dT5LxH1sWEE/#comments</comments>
		<pubDate>Tue, 31 Jan 2012 09:45:16 +0000</pubDate>
		<dc:creator>sandiegobiotech</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Syndication]]></category>
		<category><![CDATA[Xconomy]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[san diego]]></category>

		<guid isPermaLink="false">http://www.xconomy.com/?p=176955</guid>
		<description><![CDATA[Pfizer was where Pedro Lichtinger learned about pharmaceutical marketing from people who did some amazing things. For starters, New York-based Pfizer (NYSE: PFE) turned an old-school antifungal...

[[Click headline to continue reading.]]]]></description>
			<content:encoded><![CDATA[Pfizer was where Pedro Lichtinger learned about pharmaceutical marketing from people who did some amazing things. For starters, New York-based Pfizer (NYSE: PFE) turned an old-school antifungal...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/dT5LxH1sWEE" height="1" width="1"/>]]></content:encoded>
			<wfw:commentRss>http://www.xconomy.com/san-diego/2012/01/31/optimer-following-pfizers-playbook-has-big-plans-for-antibiotic/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Four Themes to Watch in Personalized Medicine</title>
		<link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/2DLdRmbwTNk/</link>
		<comments>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/2DLdRmbwTNk/#comments</comments>
		<pubDate>Mon, 30 Jan 2012 22:33:28 +0000</pubDate>
		<dc:creator>sandiegobiotech</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Syndication]]></category>
		<category><![CDATA[Xconomy]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[genomics]]></category>
		<category><![CDATA[illumina]]></category>
		<category><![CDATA[life technologies]]></category>
		<category><![CDATA[personalized medicine]]></category>
		<category><![CDATA[Pfizer]]></category>

		<guid isPermaLink="false">http://www.xconomy.com/?p=176944</guid>
		<description><![CDATA[Good morning from Mountain View, CA, and from the close of the 2012 Personalized Medicine World Conference, which brought together thought leaders of business, government, healthcare-delivery,...

[[Click headline to continue reading.]]]]></description>
			<content:encoded><![CDATA[Good morning from Mountain View, CA, and from the close of the 2012 Personalized Medicine World Conference, which brought together thought leaders of business, government, healthcare-delivery,...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/2DLdRmbwTNk" height="1" width="1"/>]]></content:encoded>
			<wfw:commentRss>http://www.xconomy.com/san-francisco/2012/01/30/four-themes-to-watch-this-year-in-personalized-medicine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vision Without Execution is Hallucination</title>
		<link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/FmiI78xDwpM/</link>
		<comments>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/FmiI78xDwpM/#comments</comments>
		<pubDate>Mon, 30 Jan 2012 16:15:35 +0000</pubDate>
		<dc:creator>sandiegobiotech</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Syndication]]></category>
		<category><![CDATA[Xconomy]]></category>
		<category><![CDATA[investing]]></category>
		<category><![CDATA[vc]]></category>

		<guid isPermaLink="false">http://www.xconomy.com/?p=176859</guid>
		<description><![CDATA[Last week Steve Case wrote an op-ed in the Washington Post called “Give Entrepreneurs Room and They Will Grow the Economy.” For those not familiar with him, Case was the founding CEO of AOL and has...

[[Click headline to continue reading.]]]]></description>
			<content:encoded><![CDATA[Last week Steve Case wrote an op-ed in the Washington Post called “Give Entrepreneurs Room and They Will Grow the Economy.” For those not familiar with him, Case was the founding CEO of AOL and has...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/FmiI78xDwpM" height="1" width="1"/>]]></content:encoded>
			<wfw:commentRss>http://www.xconomy.com/san-francisco/2012/01/30/vision-without-execution-is-hallucination/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Never Back Smug: A Lesson for Life Sciences From Newt Gingrich</title>
		<link>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/GpR4UE3xD_w/</link>
		<comments>http://feedproxy.google.com/~r/Xconomy_San_Diego_Life_Sciences/~3/GpR4UE3xD_w/#comments</comments>
		<pubDate>Mon, 30 Jan 2012 08:05:20 +0000</pubDate>
		<dc:creator>sandiegobiotech</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Syndication]]></category>
		<category><![CDATA[Xconomy]]></category>
		<category><![CDATA[biotech]]></category>

		<guid isPermaLink="false">http://www.xconomy.com/?p=176731</guid>
		<description><![CDATA[Newt Gingrich comes across on TV as someone who radiates smugness. It’s that sense that he’s not just confident in his own abilities, but extremely satisfied with his talents and his utter...

[[Click headline to continue reading.]]]]></description>
			<content:encoded><![CDATA[Newt Gingrich comes across on TV as someone who radiates smugness. It’s that sense that he’s not just confident in his own abilities, but extremely satisfied with his talents and his utter...<br/>
<br/>
[[Click headline to continue reading.]]<img src="http://feeds.feedburner.com/~r/Xconomy_San_Diego_Life_Sciences/~4/GpR4UE3xD_w" height="1" width="1"/>]]></content:encoded>
			<wfw:commentRss>http://www.xconomy.com/national/2012/01/30/never-back-smug-a-lesson-for-life-sciences-from-newt-gingrich/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

